The full activation mechanism of the adenosine A<sub>1</sub> receptor revealed by GaMD and Su-GaMD simulations.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36215480.
- Also identified by DOI 10.1073/pnas.2203702119 and PMC identifier 9586258.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The full activation process of G protein-coupled receptor (GPCR) plays an important role in cellular signal transduction. However, it remains challenging to simulate the whole process in which the GPCR is recognized and activated by a ligand and then couples to the G protein on a reasonable simulation timescale. Here, we developed a molecular dynamics (MD) approach named supervised (Su) Gaussian accelerated MD (GaMD) by incorporating a tabu-like supervision algorithm into a standard GaMD simulation. By using this Su-GaMD method, from the active and inactive structure of adenosine A<sub>1</sub> receptor (A<sub>1</sub>R), we successfully revealed the full activation mechanism of A<sub>1</sub>R, including adenosine (Ado)-A<sub>1</sub>R recognition, preactivation of A<sub>1</sub>R, and A<sub>1</sub>R-G protein recognition, in hundreds of nanoseconds of simulations. The binding of Ado to the extracellular side of A<sub>1</sub>R initiates conformational changes and the preactivation of A<sub>1</sub>R. In turn, the binding of G<sub>i2</sub> to the intracellular side of A<sub>1</sub>R causes a decrease in the volume of the extracellular orthosteric site and stabilizes the binding of Ado to A<sub>1</sub>R. Su-GaMD could be a useful tool to reconstruct or even predict ligand-protein and protein-protein recognition pathways on a short timescale. The intermediate states revealed in this study could provide more detailed complementary structural characterizations to facilitate the drug design of A<sub>1</sub>R in the future.
Medical subject headings
- Molecular Dynamics Simulation
- Receptors, Purinergic P1